Showing results (291-300 of 1,757) with videos related to
Sort By:
Pageof 176
Vascular Pharmacology|November 19, 2013
Intermittent hypoxia-induced increases in reactive oxygen species activate NFATc3 increasing endothelin-1 vasoconstrictor reactivityJ K Friedman, C H Nitta, K M Henderson, et al.Vascular Pharmacology|August 20, 2014
Lipopolysaccharide induced LOX-1 expression via TLR4/MyD88/ROS activated p38MAPK-NF-κB pathwayWenwen Zhao, Guixin Ma, Xiuping ChenVascular Pharmacology|September 3, 2014
Serotonin and sensory nerves: meeting in the cardiovascular systemStephanie W WattsVascular Pharmacology|December 3, 2014
Angiotensin type 1 and type 2 receptors during ontogeny: cardiovascular and renal effectsAngela Elena Vinturache, Francine Gabriel SmithVascular Pharmacology|July 29, 2015
Pharmacological evidence for a role of the transient receptor potential canonical 3 (TRPC3) channel in endoplasmic reticulum stress-induced apoptosis of human coronary artery endothelial cellsPrince T Ampem, Kathryn Smedlund, Guillermo VazquezVascular Pharmacology|August 12, 2017
Tail vein injection of mmLDL upregulates mouse mesenteric artery ETB receptors via activation of the ERK1/2 pathwayYang Liu, Xiao-Lan Chen, Cang-Bao Xu, et al.Vascular Pharmacology|August 24, 2017
Targeting vasa vasorum dysfunction to prevent atherosclerosisErin C Boyle, Daniel G Sedding, Axel HaverichVascular Pharmacology|June 14, 2016
Cross-talk between signaling and metabolism in the vasculatureMelanie Uebelhoer, M Luisa Iruela-ArispeVascular Pharmacology|June 18, 2016
Increase in caveolae and caveolin-1 expression modulates agonist-induced contraction and store- and receptor-operated Ca(2+) entry in pulmonary arteries of pulmonary hypertensive ratsHai-Xia Jiao, Yun-Ping Mu, Long-Xin Gui, et al.Vascular Pharmacology|May 20, 2016
Atrial fibrillation burden and atrial fibrillation type: Clinical significance and impact on the risk of stroke and decision making for long-term anticoagulationGiuseppe Boriani, Daniele PettorelliPageof 176